Greetings! By delivering this special New Year Edition of the OncoWuXi Newsletter, we would like to extend our sincere appreciation for your continued interest in OncoWuXi database, and wish you a happy, healthy and prosperous New Year! This Special Edition will bring you our full year database overview on target identification and validation, biomarker, targeted oncology, immuno-oncology, and immunology platforms. It has been our pleasure to collaborate with you throughout the year and with a deep gratitude for your continued trust and support, we look forward to serving you again in 2020!

.. Target Identification and Validation . Target identification by in vitro & in vivo CRISPR library screening Genome-wide library and customized library Target gene knockout or knockin via CRISPR/Cas9 Cell line engineering for target gene overexpression and knockdown Genetically engineered animal model 。。...。 Biomarker Platform 。 .。....... Phenotypic analysis of tumor infiltrating leukocytes with FACS In vivo phosphor flow cytometry analysis High-throughput MSD and multiplex Luminex assay Multiplex IHC, IF, RNAscope staining Nanostring CAP accredited and GCP compliant clinical biomarker analysis with FACS and IHC, IF, etc.  。...... Targeted Oncology Platform 。.... 203 CDX models 1200+ PDX models Induced drug resistant models Genetically engineered Ba/F3 models 。...... Immuno-Oncology Platform 。.... 61 syngeneic tumor models Human immune checkpoint and co-stimulatory molecules KI syngeneic tumor models Human PBMCs humanized xenograft models Checkpoint inhibitor validation and immune profiling 。。...... Immunology  Platform 。.....。.. Autoimmune & inflammatory disease animal models In vitro/Ex vivo immunology assays